Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.70
-0.70 (-4.55%)
At close: Jun 18, 2026, 4:00 PM EDT
15.05
+0.35 (2.38%)
After-hours: Jun 18, 2026, 7:29 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $772.71 million as of June 18, 2026. Its market cap has increased by 1,540.58% in one year.
Market Cap
772.71M
Enterprise Value
691.05M
1-Year Change
1,540.58%
Ranking
Category
Stock Price
$14.70
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $772.71M, an increase of 2,139.75%. That is a compound annual growth rate of 34.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 772.70M | 134.65% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 830.67M |
| Solid Biosciences | 820.09M |
| Geron | 808.32M |
| Annexon | 802.83M |
| Alto Neuroscience | 798.04M |
| Vor Biopharma | 785.15M |
| Design Therapeutics | 776.96M |
| Evommune | 769.35M |